MNI BRIEF: BOC Cutting To 3% Next Year, Ex Governor Dodge Says

MNI BRIEF: Output Gap Shut, Wage Growth Too Fast - BOE Greene

BRIEF: EU-Mercosur Deal In Final Negotiations - EC

MNI China Daily Summary: Thursday, Dec 5

MNI BRIEF: China Construction Output Slows In November

MNI: PBOC Net Drains CNY153 Bln via OMO Thursday

US EIA:NAT GAS STORAGE -30 BCF TO 3,937 BCF NOV 29 WK

MNI: CANADIAN OCT TRADE BALANCE CAD -0.9 BILLION

MNI: US OCT TRADE GAP -$73.8B VS SEP -$83.8B

MNI EXCLUSIVE: EU-Mercosur Deal Close, But Likely Short-Lived - Officials

AUSTRALIA: 2025 Election Outcome Looking More Uncertain According To Newspoll

© 1982-2024 MNI. All rights reserved.
Terms | Privacy
Log Out
Free Trial

AZ/Oxford US trial data likely to see AZ file for emergency use approval (EUA)

US

Headlines suggest that the trial data for the AZ/Oxford vaccine in the US has seen 79% of Covid-19 cases prevented with no one who contracted Covid-19 who had taken the vaccine admitted to hospital.

  • Remember that AZ was awaiting a large enough "local" trial in the US in order to seek emergency use approval (EUA) of the vaccine in the US.
  • To receive EUA, AZ must now file a request with the FDA.
  • For the Pfizer/BioNTech vaccine, a request was filed on 20 November with EUA granted on December 11 (3 week later).
  • For the Moderna vaccine a request was filed on 30 November with EUA granted on 18 December (so one working day less than 3 weeks).
Political Risk BulletFixed Income BulletsBulletMarketsPolitical RiskForeign Exchange Bullets

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.